↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Roszkowski, AP; Garay, GL; Baker, S; Schuler, M; Carter, H (1986). „Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester”. The Journal of Pharmacology and Experimental Therapeutics239 (2): 382–9. PMID3095537.
Literatura
Toshina, K.; Hirata, I.; Maemura, K.; Sasaki, S.; Murano, M.; Nitta, M.; Yamauchi, H.; Nishikawa, T. i dr.. (2000). „Enprostil, a Prostaglandin-E2 Analogue, Inhibits Interleukin-8 Production of Human Colonic Epithelial Cell Lines”. Scandinavian Journal of Immunology52 (6): 570–5. DOI:10.1046/j.1365-3083.2000.00815.x. PMID11119262.
Ching, C. K.; Lam, S. K. (1995). „A comparison of two prostaglandin analogues (enprostil vs misoprostol) in the treatment of acute duodenal ulcer disease”. Journal of Gastroenterology30 (5): 607–14. DOI:10.1007/BF02367786. PMID8574332.